Peter J Dolman
Overview
Explore the profile of Peter J Dolman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
71
Citations
634
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
North V, Dolman P, Garrity J, Kazim M
Ophthalmic Plast Reconstr Surg
. 2024 Jan;
40(2):156-160.
PMID: 38285956
Purpose: This perspective introduces the concepts of disease-modulating and -modifying therapy for thyroid eye disease and offers novel metrics for therapeutic outcomes. Methods: A focused literature review was performed. Results:...
2.
Kahaly G, Dolman P, Wolf J, Giers B, Elflein H, Jain A, et al.
J Clin Endocrinol Metab
. 2023 Jun;
108(12):3122-3134.
PMID: 37390454
Context: Inhibition of the neonatal fragment crystallizable receptor (FcRn) reduces pathogenic thyrotropin receptor antibodies (TSH-R-Ab) that drive pathology in thyroid eye disease (TED). Objective: We report the first clinical studies...
3.
Khan H, Wirth M, Dolman P, Yeung S, Iovieno A
Can J Ophthalmol
. 2023 Apr;
59(3):e200-e205.
PMID: 37028445
Objective: To investigate the long-term outcomes of fornix reconstruction and cicatricial entropion repair in patients with ocular mucous membrane pemphigoid (MMP) and secondary MMP. Methods: Retrospective chart review of patients...
4.
Burch H, Perros P, Bednarczuk T, Cooper D, Dolman P, Leung A, et al.
Thyroid
. 2022 Dec;
32(12):1439-1470.
PMID: 36480280
Thyroid eye disease (TED) remains challenging for clinicians to evaluate and manage. Novel therapies have recently emerged, and their specific roles are still being determined. Most patients with TED develop...
5.
Burch H, Perros P, Bednarczuk T, Cooper D, Dolman P, Leung A, et al.
Eur Thyroid J
. 2022 Dec;
11(6).
PMID: 36479875
Thyroid eye disease (TED) remains challenging for clinicians to evaluate and manage. Novel therapies have recently emerged, and their specific roles are still being determined. Most patients with TED develop...
6.
Nair A, Ediriwickrema L, Dolman P, Law G, Harrison A, Mokhtarzadeh A, et al.
Ophthalmic Plast Reconstr Surg
. 2022 May;
38(6):551-557.
PMID: 35551414
Purpose: To identify risk factors for the development of new-onset, postoperative diplopia following orbital decompression surgery based on patient demographics, clinical exam characteristics, radiographic parameters, and surgical techniques. Methods: We...
7.
Ming W, Terry J, Zhao L, Dolman P
Ophthalmic Plast Reconstr Surg
. 2022 Mar;
38(4):e116-e119.
PMID: 35323139
Orbital teratoma is a rare, vision-threatening, congenital neoplasm derived from all germ cell layers. The management of orbital teratoma is uncertain because of its rarity and variable severity. We present...
8.
DAlessandro P, Lo A, Spencer M, Farinha P, Armstrong L, Dolman P, et al.
Pediatr Blood Cancer
. 2022 Mar;
69(9):e29630.
PMID: 35234333
No abstract available.
9.
Wirth M, Dolman P
Ophthalmic Plast Reconstr Surg
. 2021 Mar;
37(5):496-498.
PMID: 33782328
Purpose: To describe a technique for retrieving an inferomedially migrated Jones lacrimal tube. Methods: The distal end of the migrated Jones tube is visualized directly via the nose. The tip...
10.
Chen H, Schlenker A, Dolman P, Wong V
Can J Ophthalmol
. 2021 Mar;
56(5):e155-e157.
PMID: 33744244
No abstract available.